Natural Therapeutic Partners for BCR Signaling Inhibitors

Mitchell Smith, MD Director of the Lymphoid Malignancies at Cleveland Clinic Taussig Cancer Institute discusses Natural Therapeutic Partners for BCR Signaling Inhibitors at ASH 2015